Difference between revisions of "Rebimastat (BMS-275291)"
Jump to navigation
Jump to search
(Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bms-275291 NCI Drug Dictionary]: A substance that is being studied in the t...") |
m |
||
| Line 4: | Line 4: | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
[[Category:Matrix metalloproteinase inhibitors]] | [[Category:Matrix metalloproteinase inhibitors]] | ||
| − | [[Category:Experimental | + | [[Category:Experimental]] |
[[Category:Stub]] | [[Category:Stub]] | ||
Revision as of 00:34, 3 December 2022
Mechanism of action
From the NCI Drug Dictionary: A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called matrix metalloproteinase inhibitors (MMPIs).